| 0 |
MAGNETIC RESONANCE IMAGING THORACIC ABNORMAL |
6 |
0.3333 |
| 1 |
TRACHEOBRONCHITIS BACTERIAL |
5 |
0.1923 |
| 2 |
THYROID ATROPHY |
6 |
0.0638 |
| 3 |
BASAL CELL CARCINOMA METASTATIC |
1 |
0.0588 |
| 4 |
RHEUMATOID ARTHRITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE |
4 |
0.0471 |
| 5 |
SUPERIOR SEMICIRCULAR CANAL DEHISCENCE |
1 |
0.0435 |
| 6 |
WHITE BLOOD CELLS STOOL POSITIVE |
1 |
0.0256 |
| 7 |
ORTHOSTATIC TREMOR |
1 |
0.0238 |
| 8 |
GENITAL HERPES SIMPLEX |
5 |
0.0236 |
| 9 |
CONNECTIVE TISSUE DISEASE-ASSOCIATED INTERSTITIAL LUNG DISEASE |
1 |
0.0182 |
| 10 |
ANEURYSM REPAIR |
2 |
0.0175 |
| 11 |
NEUROMUSCULAR PAIN |
1 |
0.0172 |
| 12 |
BACTERIAL TRACHEITIS |
1 |
0.0123 |
| 13 |
ANIMAL ATTACK |
1 |
0.0115 |
| 14 |
INTERCEPTED PRODUCT ADMINISTRATION ERROR |
75 |
0.0098 |
| 15 |
URTICARIA CHRONIC |
5 |
0.0089 |
| 16 |
PERIPHERAL NERVE PALSY |
1 |
0.0088 |
| 17 |
BRONCHIAL WALL THICKENING |
6 |
0.0083 |
| 18 |
PERIPORTAL OEDEMA |
1 |
0.0080 |
| 19 |
PORTAL TRACT INFLAMMATION |
1 |
0.0079 |
| 20 |
BRONCHITIS BACTERIAL |
6 |
0.0079 |
| 21 |
TRACHEOBRONCHITIS |
6 |
0.0078 |
| 22 |
PRODUCT COMMUNICATION ISSUE |
68 |
0.0077 |
| 23 |
HILAR LYMPHADENOPATHY |
6 |
0.0068 |
| 24 |
PERINEAL INJURY |
1 |
0.0066 |
| 25 |
HAEMOPHILUS INFECTION |
6 |
0.0061 |
| 26 |
SOCIOECONOMIC PRECARITY |
1 |
0.0058 |
| 27 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
194 |
0.0057 |
| 28 |
DEVICE DIFFICULT TO USE |
379 |
0.0057 |
| 29 |
SICCA SYNDROME |
1 |
0.0052 |
| 30 |
MUCOSAL HAEMORRHAGE |
6 |
0.0052 |
| 31 |
CORTISOL ABNORMAL |
1 |
0.0050 |
| 32 |
DRUG SPECIFIC ANTIBODY ABSENT |
1 |
0.0049 |
| 33 |
CYSTITIS NONINFECTIVE |
6 |
0.0045 |
| 34 |
BRONCHIAL OBSTRUCTION |
6 |
0.0043 |
| 35 |
DRAINAGE |
2 |
0.0041 |
| 36 |
CONJUNCTIVITIS ALLERGIC |
6 |
0.0040 |
| 37 |
VIBRATORY SENSE INCREASED |
1 |
0.0039 |
| 38 |
PRODUCT KNOWLEDGE DEFICIT |
3 |
0.0038 |
| 39 |
GROWTH DISORDER |
1 |
0.0037 |
| 40 |
AGITATED DEPRESSION |
1 |
0.0035 |
| 41 |
INCORRECT DISPOSAL OF PRODUCT |
11 |
0.0034 |
| 42 |
PRODUCT STORAGE ERROR |
280 |
0.0032 |
| 43 |
DRUG DOSE OMISSION BY DEVICE |
247 |
0.0032 |
| 44 |
TRAUMATIC LUNG INJURY |
6 |
0.0031 |
| 45 |
OSTEOTOMY |
1 |
0.0031 |
| 46 |
HEMIPLEGIC MIGRAINE |
1 |
0.0029 |
| 47 |
STIFF PERSON SYNDROME |
1 |
0.0029 |
| 48 |
HEMIHYPOAESTHESIA |
1 |
0.0028 |
| 49 |
TINEA VERSICOLOUR |
1 |
0.0028 |
| 50 |
INJECTION SITE INDENTATION |
6 |
0.0028 |
| 51 |
MILIA |
1 |
0.0028 |
| 52 |
INFECTION SUSCEPTIBILITY INCREASED |
6 |
0.0027 |
| 53 |
INJECTION SITE PUSTULE |
1 |
0.0026 |
| 54 |
ARACHNOID CYST |
1 |
0.0025 |
| 55 |
BLOOD IMMUNOGLOBULIN E INCREASED |
6 |
0.0025 |
| 56 |
PRODUCT SUBSTITUTION |
1 |
0.0025 |
| 57 |
ATRIAL TACHYCARDIA |
5 |
0.0024 |
| 58 |
EXPOSURE VIA EYE CONTACT |
1 |
0.0024 |
| 59 |
INFECTED BITE |
2 |
0.0024 |
| 60 |
INTERCEPTED PRODUCT STORAGE ERROR |
8 |
0.0022 |
| 61 |
AORTIC ARTERIOSCLEROSIS |
5 |
0.0019 |
| 62 |
ENTHESOPATHY |
3 |
0.0019 |
| 63 |
C-REACTIVE PROTEIN ABNORMAL |
12 |
0.0019 |
| 64 |
COLONOSCOPY |
4 |
0.0018 |
| 65 |
BONE FRAGMENTATION |
1 |
0.0018 |
| 66 |
RED BLOOD CELL SEDIMENTATION RATE ABNORMAL |
4 |
0.0017 |
| 67 |
VERTIGO POSITIONAL |
3 |
0.0017 |
| 68 |
VULVAL CANCER |
1 |
0.0017 |
| 69 |
BRONCHIECTASIS |
11 |
0.0016 |
| 70 |
POST PROCEDURAL INFLAMMATION |
1 |
0.0016 |
| 71 |
CHRONIC SINUSITIS |
6 |
0.0016 |
| 72 |
ACCIDENTAL EXPOSURE TO PRODUCT |
164 |
0.0016 |
| 73 |
CUTANEOUS T-CELL LYMPHOMA |
2 |
0.0016 |
| 74 |
PERIORAL DERMATITIS |
1 |
0.0016 |
| 75 |
GINGIVAL DISCOMFORT |
1 |
0.0015 |
| 76 |
LIP EXFOLIATION |
2 |
0.0015 |
| 77 |
POST PROCEDURAL SEPSIS |
1 |
0.0015 |
| 78 |
HEPATIC CYST |
5 |
0.0015 |
| 79 |
NEUROENDOCRINE CARCINOMA |
1 |
0.0014 |
| 80 |
BRONCHIOLITIS |
5 |
0.0014 |
| 81 |
INJURY ASSOCIATED WITH DEVICE |
28 |
0.0014 |
| 82 |
BENIGN NEOPLASM OF THYROID GLAND |
1 |
0.0014 |
| 83 |
SMALL CELL LUNG CANCER |
2 |
0.0013 |
| 84 |
AUTOIMMUNE THYROIDITIS |
5 |
0.0013 |
| 85 |
SQUAMOUS CELL CARCINOMA OF LUNG |
1 |
0.0013 |
| 86 |
VEIN COLLAPSE |
1 |
0.0013 |
| 87 |
GENITAL ULCERATION |
1 |
0.0013 |
| 88 |
MYCOPLASMA INFECTION |
1 |
0.0013 |
| 89 |
PRODUCT CONFUSION |
1 |
0.0013 |
| 90 |
OCCUPATIONAL EXPOSURE TO PRODUCT |
8 |
0.0012 |
| 91 |
EXPOSURE VIA SKIN CONTACT |
32 |
0.0012 |
| 92 |
DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED PRODUCT |
1 |
0.0012 |
| 93 |
BREATH SOUNDS ABNORMAL |
6 |
0.0012 |
| 94 |
GIANT CELL ARTERITIS |
1 |
0.0012 |
| 95 |
INCREASED UPPER AIRWAY SECRETION |
6 |
0.0012 |
| 96 |
CRANIOFACIAL FRACTURE |
1 |
0.0012 |
| 97 |
ABSCESS DRAINAGE |
1 |
0.0012 |
| 98 |
INCORRECT DOSE ADMINISTERED BY DEVICE |
30 |
0.0011 |
| 99 |
BLOOD CREATINE INCREASED |
5 |
0.0011 |
| 100 |
HUMAN CHORIONIC GONADOTROPIN INCREASED |
1 |
0.0011 |
| 101 |
LIGAMENT DISORDER |
1 |
0.0011 |
| 102 |
DEVICE USE ERROR |
38 |
0.0011 |
| 103 |
SKIN GRAFT |
1 |
0.0011 |
| 104 |
INJECTION SITE CELLULITIS |
2 |
0.0011 |
| 105 |
ARNOLD-CHIARI MALFORMATION |
1 |
0.0010 |
| 106 |
CORRECTIVE LENS USER |
1 |
0.0010 |
| 107 |
MASTOIDITIS |
1 |
0.0010 |
| 108 |
DILATED CARDIOMYOPATHY |
1 |
0.0010 |
| 109 |
FEAR OF INJECTION |
7 |
0.0010 |
| 110 |
INJECTION SITE HYPERSENSITIVITY |
3 |
0.0010 |
| 111 |
PANCREATIC MASS |
1 |
0.0009 |
| 112 |
FOETAL MALFORMATION |
1 |
0.0009 |
| 113 |
ONYCHOMYCOSIS |
4 |
0.0009 |
| 114 |
ADVERSE REACTION |
12 |
0.0009 |
| 115 |
RHEUMATOID FACTOR POSITIVE |
5 |
0.0009 |
| 116 |
OSTEOCHONDROSIS |
1 |
0.0009 |
| 117 |
VITILIGO |
2 |
0.0009 |
| 118 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR |
2 |
0.0008 |
| 119 |
ENCEPHALITIS VIRAL |
1 |
0.0008 |
| 120 |
JUVENILE IDIOPATHIC ARTHRITIS |
2 |
0.0008 |
| 121 |
AORTIC VALVE REPLACEMENT |
1 |
0.0008 |
| 122 |
LUPUS VULGARIS |
1 |
0.0008 |
| 123 |
BETA HAEMOLYTIC STREPTOCOCCAL INFECTION |
1 |
0.0008 |
| 124 |
FISTULA DISCHARGE |
1 |
0.0008 |
| 125 |
ABDOMINAL OPERATION |
1 |
0.0008 |
| 126 |
PULMONARY HAEMORRHAGE |
6 |
0.0008 |
| 127 |
POSTPARTUM HAEMORRHAGE |
1 |
0.0007 |
| 128 |
PERIPHERAL VENOUS DISEASE |
3 |
0.0007 |
| 129 |
DRUG SPECIFIC ANTIBODY |
1 |
0.0007 |
| 130 |
INJECTION SITE INJURY |
4 |
0.0007 |
| 131 |
ONYCHOMADESIS |
3 |
0.0007 |
| 132 |
HAND FRACTURE |
5 |
0.0007 |
| 133 |
PRODUCT ADMINISTRATION ERROR |
14 |
0.0007 |
| 134 |
LABELLED DRUG-DRUG INTERACTION ISSUE |
1 |
0.0007 |
| 135 |
MUTISM |
1 |
0.0007 |
| 136 |
CARDIAC FIBRILLATION |
1 |
0.0007 |
| 137 |
RHEUMATIC FEVER |
3 |
0.0007 |
| 138 |
GASTROINTESTINAL WALL THICKENING |
1 |
0.0007 |
| 139 |
HYPOSMIA |
1 |
0.0007 |
| 140 |
VASCULAR RUPTURE |
1 |
0.0006 |
| 141 |
FAECAL CALPROTECTIN INCREASED |
2 |
0.0006 |
| 142 |
NASAL ULCER |
1 |
0.0006 |
| 143 |
SCLERITIS |
1 |
0.0006 |
| 144 |
FACET JOINT SYNDROME |
2 |
0.0006 |
| 145 |
PULMONARY ARTERIAL PRESSURE INCREASED |
1 |
0.0006 |
| 146 |
SHOULDER FRACTURE |
1 |
0.0006 |
| 147 |
INJECTION RELATED REACTION |
1 |
0.0006 |
| 148 |
INFLAMMATORY MARKER INCREASED |
3 |
0.0006 |
| 149 |
BLOOD CALCIUM ABNORMAL |
1 |
0.0006 |
| 150 |
LIVE BIRTH |
5 |
0.0006 |
| 151 |
SKIN WOUND |
1 |
0.0006 |
| 152 |
PRODUCT TEMPERATURE EXCURSION ISSUE |
3 |
0.0006 |
| 153 |
AMYLOIDOSIS |
1 |
0.0006 |
| 154 |
MUSCLE STRAIN |
5 |
0.0006 |
| 155 |
BREAST CYST |
1 |
0.0006 |
| 156 |
CARDIAC ABLATION |
1 |
0.0006 |
| 157 |
X-RAY ABNORMAL |
1 |
0.0006 |
| 158 |
INTRA-ABDOMINAL FLUID COLLECTION |
1 |
0.0006 |
| 159 |
HIDRADENITIS |
5 |
0.0005 |
| 160 |
UROSEPSIS |
5 |
0.0005 |
| 161 |
CEREBROSPINAL FLUID LEAKAGE |
1 |
0.0005 |
| 162 |
PRODUCT PREPARATION ERROR |
11 |
0.0005 |
| 163 |
LIP DISORDER |
1 |
0.0005 |
| 164 |
PRODUCT STORAGE ISSUE |
2 |
0.0005 |
| 165 |
SUPRAVENTRICULAR TACHYCARDIA |
5 |
0.0005 |
| 166 |
DRUG DELIVERY SYSTEM ISSUE |
1 |
0.0005 |
| 167 |
VOCAL CORD DISORDER |
1 |
0.0005 |
| 168 |
DEEP VEIN THROMBOSIS POSTOPERATIVE |
1 |
0.0005 |
| 169 |
EAR HAEMORRHAGE |
1 |
0.0005 |
| 170 |
MATERNAL EXPOSURE DURING BREAST FEEDING |
2 |
0.0005 |
| 171 |
THERAPY INTERRUPTED |
35 |
0.0005 |
| 172 |
DERMATITIS PSORIASIFORM |
1 |
0.0005 |
| 173 |
INJECTION SITE URTICARIA |
12 |
0.0005 |
| 174 |
SPINAL COMPRESSION FRACTURE |
4 |
0.0005 |
| 175 |
ADJUSTMENT DISORDER WITH DEPRESSED MOOD |
1 |
0.0005 |
| 176 |
LATENT TUBERCULOSIS |
1 |
0.0005 |
| 177 |
DRUG EFFECT LESS THAN EXPECTED |
7 |
0.0005 |
| 178 |
INCORRECT DRUG ADMINISTRATION RATE |
2 |
0.0005 |
| 179 |
IMMUNODEFICIENCY |
7 |
0.0005 |
| 180 |
PULMONARY FIBROSIS |
9 |
0.0005 |
| 181 |
PRODUCT DISPENSING ISSUE |
2 |
0.0005 |
| 182 |
HIATUS HERNIA |
6 |
0.0005 |
| 183 |
OBSTRUCTIVE AIRWAYS DISORDER |
5 |
0.0004 |
| 184 |
RHEUMATOID ARTHRITIS |
51 |
0.0004 |
| 185 |
OSTEOMYELITIS |
8 |
0.0004 |
| 186 |
LUPUS-LIKE SYNDROME |
4 |
0.0004 |
| 187 |
DISLOCATION OF VERTEBRA |
1 |
0.0004 |
| 188 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
87 |
0.0004 |
| 189 |
FEELING OF DESPAIR |
2 |
0.0004 |
| 190 |
ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE |
3 |
0.0004 |
| 191 |
HYPERTHYROIDISM |
6 |
0.0004 |
| 192 |
FINGER DEFORMITY |
2 |
0.0004 |
| 193 |
COELIAC DISEASE |
4 |
0.0004 |
| 194 |
INJECTION SITE PAIN |
125 |
0.0004 |
| 195 |
CEREBRAL DISORDER |
3 |
0.0004 |
| 196 |
FOOT OPERATION |
2 |
0.0004 |
| 197 |
INJECTION SITE HAEMORRHAGE |
32 |
0.0004 |
| 198 |
ERYSIPELAS |
2 |
0.0004 |
| 199 |
DRUG TOLERANCE |
2 |
0.0004 |
| 200 |
LIPOMA |
1 |
0.0004 |
| 201 |
NASAL DISORDER |
1 |
0.0004 |
| 202 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
1 |
0.0004 |
| 203 |
ANAL FISTULA |
2 |
0.0004 |
| 204 |
PSORIATIC ARTHROPATHY |
15 |
0.0004 |
| 205 |
HIP SURGERY |
2 |
0.0004 |
| 206 |
INVASIVE DUCTAL BREAST CARCINOMA |
1 |
0.0004 |
| 207 |
CLUMSINESS |
1 |
0.0004 |
| 208 |
ULCERATIVE KERATITIS |
1 |
0.0004 |
| 209 |
NONSPECIFIC REACTION |
2 |
0.0004 |
| 210 |
MACULE |
1 |
0.0004 |
| 211 |
INJECTION SITE RASH |
11 |
0.0004 |
| 212 |
PROCTITIS |
1 |
0.0004 |
| 213 |
MACULAR OEDEMA |
2 |
0.0004 |
| 214 |
MULTIPLE USE OF SINGLE-USE PRODUCT |
2 |
0.0004 |
| 215 |
DRUG TOLERANCE DECREASED |
1 |
0.0004 |
| 216 |
INJECTION SITE SCAR |
1 |
0.0004 |
| 217 |
PRODUCT LABEL CONFUSION |
2 |
0.0003 |
| 218 |
GASTROINTESTINAL NECROSIS |
1 |
0.0003 |
| 219 |
NAIL DISORDER |
3 |
0.0003 |
| 220 |
GRIP STRENGTH DECREASED |
3 |
0.0003 |
| 221 |
TOOTH DISCOLOURATION |
1 |
0.0003 |
| 222 |
INFUSION SITE REACTION |
1 |
0.0003 |
| 223 |
ATYPICAL PNEUMONIA |
1 |
0.0003 |
| 224 |
SYNOVITIS |
6 |
0.0003 |
| 225 |
INJECTION SITE VESICLES |
2 |
0.0003 |
| 226 |
CONTRAINDICATED PRODUCT ADMINISTERED |
10 |
0.0003 |
| 227 |
OSTEOPENIA |
5 |
0.0003 |
| 228 |
EYE INJURY |
1 |
0.0003 |
| 229 |
INJECTION SITE REACTION |
22 |
0.0003 |
| 230 |
BRAIN FOG |
5 |
0.0003 |
| 231 |
BLEPHAROSPASM |
2 |
0.0003 |
| 232 |
HEPATITIS B REACTIVATION |
1 |
0.0003 |
| 233 |
BLADDER PAIN |
1 |
0.0003 |
| 234 |
LOSS OF THERAPEUTIC RESPONSE |
1 |
0.0003 |
| 235 |
SWOLLEN JOINT COUNT INCREASED |
1 |
0.0003 |
| 236 |
INJECTION SITE BRUISING |
25 |
0.0003 |
| 237 |
PROCTALGIA |
2 |
0.0003 |
| 238 |
BREAST CANCER STAGE III |
2 |
0.0003 |
| 239 |
AUTOIMMUNE DISORDER |
3 |
0.0003 |
| 240 |
THERAPY CHANGE |
3 |
0.0003 |
| 241 |
PRODUCT PREPARATION ISSUE |
2 |
0.0003 |
| 242 |
NEAR DEATH EXPERIENCE |
1 |
0.0003 |
| 243 |
SARS-COV-2 TEST POSITIVE |
4 |
0.0003 |
| 244 |
OTITIS MEDIA |
1 |
0.0003 |
| 245 |
BLADDER DISORDER |
3 |
0.0003 |
| 246 |
LYME DISEASE |
1 |
0.0003 |
| 247 |
ANXIETY DISORDER |
1 |
0.0003 |
| 248 |
PLANTAR FASCIITIS |
1 |
0.0003 |
| 249 |
POSTOPERATIVE WOUND INFECTION |
2 |
0.0003 |
| 250 |
ULCER HAEMORRHAGE |
2 |
0.0003 |
| 251 |
PUSTULAR PSORIASIS |
1 |
0.0003 |
| 252 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
13 |
0.0003 |
| 253 |
JOINT EFFUSION |
2 |
0.0003 |
| 254 |
CERVICAL VERTEBRAL FRACTURE |
1 |
0.0003 |
| 255 |
FOLLICULITIS |
3 |
0.0003 |
| 256 |
BONE EROSION |
1 |
0.0003 |
| 257 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
20 |
0.0003 |
| 258 |
PYODERMA GANGRENOSUM |
1 |
0.0003 |
| 259 |
LIQUID PRODUCT PHYSICAL ISSUE |
2 |
0.0003 |
| 260 |
FOOD INTOLERANCE |
1 |
0.0003 |
| 261 |
THROMBOCYTOSIS |
1 |
0.0003 |
| 262 |
RECTAL DISCHARGE |
1 |
0.0003 |
| 263 |
INFLAMMATION |
14 |
0.0003 |
| 264 |
RED BLOOD CELL SEDIMENTATION RATE INCREASED |
3 |
0.0003 |
| 265 |
NERVE INJURY |
3 |
0.0003 |
| 266 |
DUODENAL ULCER PERFORATION |
2 |
0.0003 |
| 267 |
RESPIRATORY TRACT INFECTION |
7 |
0.0003 |
| 268 |
TREATMENT FAILURE |
22 |
0.0003 |
| 269 |
CHEMOTHERAPY |
1 |
0.0003 |
| 270 |
FOOT FRACTURE |
5 |
0.0003 |
| 271 |
GASTRIC INFECTION |
1 |
0.0003 |
| 272 |
OESOPHAGEAL DISORDER |
1 |
0.0003 |
| 273 |
VULVOVAGINAL MYCOTIC INFECTION |
1 |
0.0003 |
| 274 |
DISABILITY |
5 |
0.0003 |
| 275 |
SPINAL FUSION SURGERY |
1 |
0.0002 |
| 276 |
POST PROCEDURAL INFECTION |
2 |
0.0002 |
| 277 |
INTENTIONAL DOSE OMISSION |
7 |
0.0002 |
| 278 |
POLYURIA |
2 |
0.0002 |
| 279 |
SPINAL OPERATION |
3 |
0.0002 |
| 280 |
STAPHYLOCOCCAL INFECTION |
8 |
0.0002 |
| 281 |
MUSCLE INJURY |
2 |
0.0002 |
| 282 |
INJECTION SITE DISCOLOURATION |
3 |
0.0002 |
| 283 |
PEMPHIGUS |
3 |
0.0002 |
| 284 |
THROAT CANCER |
1 |
0.0002 |
| 285 |
HEPATITIS |
6 |
0.0002 |
| 286 |
SHOULDER OPERATION |
1 |
0.0002 |
| 287 |
CHAPPED LIPS |
1 |
0.0002 |
| 288 |
HAND DEFORMITY |
3 |
0.0002 |
| 289 |
DIVERTICULUM INTESTINAL |
1 |
0.0002 |
| 290 |
IMMUNE SYSTEM DISORDER |
3 |
0.0002 |
| 291 |
ANKYLOSING SPONDYLITIS |
3 |
0.0002 |
| 292 |
JOINT RANGE OF MOTION DECREASED |
3 |
0.0002 |
| 293 |
LIP DRY |
2 |
0.0002 |
| 294 |
URINE ABNORMALITY |
1 |
0.0002 |
| 295 |
EXOSTOSIS |
2 |
0.0002 |
| 296 |
DISEASE COMPLICATION |
1 |
0.0002 |
| 297 |
EAR DISORDER |
1 |
0.0002 |
| 298 |
EYE OPERATION |
1 |
0.0002 |
| 299 |
CHRONIC MYELOID LEUKAEMIA |
1 |
0.0002 |
| 300 |
HAEMOPTYSIS |
6 |
0.0002 |
| 301 |
THERAPY CESSATION |
11 |
0.0002 |
| 302 |
SLEEP DISORDER |
15 |
0.0002 |
| 303 |
MUSCULOSKELETAL DISORDER |
4 |
0.0002 |
| 304 |
GAIT INABILITY |
7 |
0.0002 |
| 305 |
LIMB OPERATION |
1 |
0.0002 |
| 306 |
HYPERCHOLESTEROLAEMIA |
2 |
0.0002 |
| 307 |
GUILLAIN-BARRE SYNDROME |
1 |
0.0002 |
| 308 |
ORAL HERPES |
4 |
0.0002 |
| 309 |
INFLAMMATORY BOWEL DISEASE |
2 |
0.0002 |
| 310 |
PHARYNGEAL SWELLING |
2 |
0.0002 |
| 311 |
RENAL CELL CARCINOMA |
1 |
0.0002 |
| 312 |
NASAL POLYPS |
1 |
0.0002 |
| 313 |
ABDOMINAL TENDERNESS |
1 |
0.0002 |
| 314 |
HEPATIC ENZYME ABNORMAL |
1 |
0.0002 |
| 315 |
HELICOBACTER INFECTION |
2 |
0.0002 |
| 316 |
TRISMUS |
1 |
0.0002 |
| 317 |
SENSITIVITY TO WEATHER CHANGE |
1 |
0.0002 |
| 318 |
KNEE ARTHROPLASTY |
4 |
0.0002 |
| 319 |
GASTROINTESTINAL MOTILITY DISORDER |
1 |
0.0002 |
| 320 |
COMPRESSION FRACTURE |
1 |
0.0002 |
| 321 |
INTESTINAL RESECTION |
1 |
0.0002 |
| 322 |
ANAL ABSCESS |
1 |
0.0002 |
| 323 |
PHARYNGITIS STREPTOCOCCAL |
2 |
0.0002 |
| 324 |
BACK INJURY |
2 |
0.0002 |
| 325 |
LUNG DISORDER |
9 |
0.0002 |
| 326 |
HYDROCEPHALUS |
1 |
0.0002 |
| 327 |
WOUND INFECTION |
2 |
0.0002 |
| 328 |
DRUG LEVEL BELOW THERAPEUTIC |
1 |
0.0002 |
| 329 |
INTERMENSTRUAL BLEEDING |
1 |
0.0002 |
| 330 |
PERICARDITIS |
3 |
0.0002 |
| 331 |
SKIN INFECTION |
2 |
0.0002 |
| 332 |
PRODUCT LEAKAGE |
1 |
0.0002 |
| 333 |
FISTULA |
2 |
0.0002 |
| 334 |
HEPATIC ENZYME INCREASED |
12 |
0.0002 |
| 335 |
PERONEAL NERVE PALSY |
1 |
0.0002 |
| 336 |
GASTRIC DISORDER |
6 |
0.0002 |
| 337 |
JOINT SWELLING |
21 |
0.0002 |
| 338 |
HERPES VIRUS INFECTION |
1 |
0.0002 |
| 339 |
VASCULITIS |
2 |
0.0002 |
| 340 |
SPINAL PAIN |
2 |
0.0002 |
| 341 |
FEELING OF BODY TEMPERATURE CHANGE |
1 |
0.0002 |
| 342 |
INJECTION SITE SWELLING |
13 |
0.0002 |
| 343 |
GLUCOSE TOLERANCE IMPAIRED |
1 |
0.0002 |
| 344 |
CATARACT OPERATION |
1 |
0.0002 |
| 345 |
SYMPTOM RECURRENCE |
1 |
0.0002 |
| 346 |
BLOOD PRESSURE INADEQUATELY CONTROLLED |
1 |
0.0002 |
| 347 |
C-REACTIVE PROTEIN INCREASED |
6 |
0.0002 |
| 348 |
BURSITIS |
2 |
0.0002 |
| 349 |
SCOLIOSIS |
1 |
0.0002 |
| 350 |
INFUSION SITE EXTRAVASATION |
1 |
0.0002 |
| 351 |
BRAIN OEDEMA |
2 |
0.0002 |
| 352 |
PHOTOPSIA |
1 |
0.0002 |
| 353 |
THERAPEUTIC RESPONSE CHANGED |
1 |
0.0002 |
| 354 |
PULMONARY OEDEMA |
7 |
0.0002 |
| 355 |
THERAPY NON-RESPONDER |
7 |
0.0002 |
| 356 |
DRUG INTOLERANCE |
15 |
0.0002 |
| 357 |
SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE |
1 |
0.0002 |
| 358 |
DRUG SPECIFIC ANTIBODY PRESENT |
1 |
0.0002 |
| 359 |
PLATELET COUNT INCREASED |
2 |
0.0002 |
| 360 |
DYSPEPSIA |
15 |
0.0002 |
| 361 |
WALKING AID USER |
1 |
0.0002 |
| 362 |
SKIN DISORDER |
5 |
0.0001 |
| 363 |
PREGNANCY |
3 |
0.0001 |
| 364 |
SKIN MASS |
1 |
0.0001 |
| 365 |
INJECTION SITE PRURITUS |
10 |
0.0001 |
| 366 |
MUSCULOSKELETAL STIFFNESS |
13 |
0.0001 |
| 367 |
TASTE DISORDER |
3 |
0.0001 |
| 368 |
VERTIGO |
9 |
0.0001 |
| 369 |
UVEITIS |
2 |
0.0001 |
| 370 |
PRODUCT LABEL ISSUE |
1 |
0.0001 |
| 371 |
MATERNAL EXPOSURE BEFORE PREGNANCY |
1 |
0.0001 |
| 372 |
INJECTION SITE WARMTH |
3 |
0.0001 |
| 373 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
7 |
0.0001 |
| 374 |
ADVERSE DRUG REACTION |
13 |
0.0001 |
| 375 |
LYMPHOEDEMA |
1 |
0.0001 |
| 376 |
ARTHROPATHY |
8 |
0.0001 |
| 377 |
ABDOMINAL DISTENSION |
15 |
0.0001 |
| 378 |
WOUND |
4 |
0.0001 |
| 379 |
DEFAECATION URGENCY |
1 |
0.0001 |
| 380 |
SEASONAL ALLERGY |
2 |
0.0001 |
| 381 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
5 |
0.0001 |
| 382 |
ARTHRITIS |
11 |
0.0001 |
| 383 |
LIVER FUNCTION TEST INCREASED |
3 |
0.0001 |
| 384 |
IMPAIRED QUALITY OF LIFE |
2 |
0.0001 |
| 385 |
PRODUCT DISPENSING ERROR |
3 |
0.0001 |
| 386 |
FAECES SOFT |
1 |
0.0001 |
| 387 |
ORAL DISORDER |
1 |
0.0001 |
| 388 |
ARTHROPOD BITE |
1 |
0.0001 |
| 389 |
COLITIS ULCERATIVE |
6 |
0.0001 |
| 390 |
SUNBURN |
1 |
0.0001 |
| 391 |
GLOSSODYNIA |
3 |
0.0001 |
| 392 |
GENERAL SYMPTOM |
1 |
0.0001 |
| 393 |
PEMPHIGOID |
1 |
0.0001 |
| 394 |
ILL-DEFINED DISORDER |
8 |
0.0001 |
| 395 |
INSURANCE ISSUE |
2 |
0.0001 |
| 396 |
HIP ARTHROPLASTY |
2 |
0.0001 |
| 397 |
PSORIASIS |
17 |
0.0001 |
| 398 |
CONGENITAL ANOMALY |
1 |
0.0001 |
| 399 |
HYPOALBUMINAEMIA |
1 |
0.0001 |
| 400 |
PRODUCT ADMINISTRATION INTERRUPTED |
1 |
0.0001 |
| 401 |
ARTERIAL OCCLUSIVE DISEASE |
1 |
0.0001 |
| 402 |
FURUNCLE |
1 |
0.0001 |
| 403 |
OBESITY |
2 |
0.0001 |
| 404 |
ABSCESS |
2 |
0.0001 |
| 405 |
SENSORY LOSS |
1 |
0.0001 |
| 406 |
NIGHT SWEATS |
4 |
0.0001 |
| 407 |
STENT PLACEMENT |
1 |
0.0001 |
| 408 |
MYASTHENIA GRAVIS |
1 |
0.0001 |
| 409 |
FRUSTRATION TOLERANCE DECREASED |
1 |
0.0001 |
| 410 |
LIVER INJURY |
3 |
0.0001 |
| 411 |
ABNORMAL FAECES |
1 |
0.0001 |
| 412 |
MULTIPLE FRACTURES |
2 |
0.0001 |
| 413 |
HYPERAESTHESIA |
1 |
0.0001 |
| 414 |
UPPER-AIRWAY COUGH SYNDROME |
1 |
0.0001 |
| 415 |
GENERAL PHYSICAL HEALTH DETERIORATION |
14 |
0.0001 |
| 416 |
MENSTRUAL DISORDER |
1 |
0.0001 |
| 417 |
BREAST CANCER STAGE II |
1 |
0.0001 |
| 418 |
URTICARIA |
20 |
0.0001 |
| 419 |
CONDITION AGGRAVATED |
36 |
0.0001 |
| 420 |
SWELLING |
11 |
0.0001 |
| 421 |
FACIAL PARALYSIS |
1 |
0.0001 |
| 422 |
SCAR |
2 |
0.0001 |
| 423 |
ILLNESS |
12 |
0.0001 |
| 424 |
PSYCHOLOGICAL TRAUMA |
1 |
0.0001 |
| 425 |
PAIN |
71 |
0.0001 |
| 426 |
HYSTERECTOMY |
1 |
0.0001 |
| 427 |
MUCOSAL INFLAMMATION |
3 |
0.0001 |
| 428 |
DEVICE USE ISSUE |
2 |
0.0001 |
| 429 |
COLD SWEAT |
2 |
0.0001 |
| 430 |
INJECTION SITE ERYTHEMA |
14 |
0.0001 |
| 431 |
MATERNAL EXPOSURE DURING PREGNANCY |
10 |
0.0001 |
| 432 |
HEAVY MENSTRUAL BLEEDING |
1 |
0.0001 |
| 433 |
OROPHARYNGEAL DISCOMFORT |
1 |
0.0001 |
| 434 |
OPTIC NEURITIS |
1 |
0.0001 |
| 435 |
SKIN LESION |
3 |
0.0001 |
| 436 |
PNEUMONIA BACTERIAL |
1 |
0.0001 |
| 437 |
DIVERTICULITIS |
3 |
0.0001 |
| 438 |
THINKING ABNORMAL |
2 |
0.0001 |
| 439 |
NEPHROPATHY |
1 |
0.0001 |
| 440 |
WRONG TECHNIQUE IN DEVICE USAGE PROCESS |
5 |
0.0001 |
| 441 |
FLANK PAIN |
1 |
0.0001 |
| 442 |
PHOTOPHOBIA |
2 |
0.0001 |
| 443 |
EYE INFLAMMATION |
1 |
0.0001 |
| 444 |
POST PROCEDURAL COMPLICATION |
2 |
0.0001 |
| 445 |
LOWER LIMB FRACTURE |
2 |
0.0001 |
| 446 |
ERUCTATION |
2 |
0.0001 |
| 447 |
HYPERSENSITIVITY |
19 |
0.0001 |
| 448 |
SURGERY |
6 |
0.0001 |
| 449 |
DECREASED IMMUNE RESPONSIVENESS |
1 |
0.0001 |
| 450 |
HEPATOMEGALY |
1 |
0.0001 |
| 451 |
VITREOUS FLOATERS |
1 |
0.0001 |
| 452 |
KNEE OPERATION |
1 |
0.0001 |
| 453 |
LIGAMENT SPRAIN |
1 |
0.0001 |
| 454 |
INABILITY TO AFFORD MEDICATION |
1 |
0.0001 |
| 455 |
BLOOD PRESSURE ABNORMAL |
2 |
0.0001 |
| 456 |
DISCOMFORT |
6 |
0.0001 |
| 457 |
DRUG LEVEL DECREASED |
1 |
0.0001 |
| 458 |
INITIAL INSOMNIA |
1 |
0.0001 |
| 459 |
RIB FRACTURE |
2 |
0.0001 |
| 460 |
ARTHRALGIA |
40 |
0.0001 |
| 461 |
PETECHIAE |
1 |
0.0001 |
| 462 |
NERVOUSNESS |
5 |
0.0001 |
| 463 |
UNINTENDED PREGNANCY |
1 |
0.0001 |
| 464 |
DRUG-INDUCED LIVER INJURY |
3 |
0.0001 |
| 465 |
ECZEMA |
5 |
0.0001 |
| 466 |
JOINT DISLOCATION |
1 |
0.0001 |
| 467 |
BRONCHITIS |
7 |
0.0001 |
| 468 |
OSTEOARTHRITIS |
4 |
0.0001 |
| 469 |
IRRITABLE BOWEL SYNDROME |
2 |
0.0001 |
| 470 |
RECTAL HAEMORRHAGE |
4 |
0.0001 |
| 471 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
2 |
0.0001 |
| 472 |
EYE DISORDER |
3 |
0.0001 |
| 473 |
BLOOD PRESSURE DECREASED |
6 |
0.0001 |
| 474 |
NEOPLASM MALIGNANT |
6 |
0.0001 |
| 475 |
MALNUTRITION |
1 |
0.0001 |
| 476 |
EYE PRURITUS |
3 |
0.0001 |
| 477 |
SNEEZING |
2 |
0.0001 |
| 478 |
TYPE 2 DIABETES MELLITUS |
3 |
0.0001 |
| 479 |
BLISTER |
5 |
0.0001 |
| 480 |
IMPAIRED DRIVING ABILITY |
1 |
0.0001 |
| 481 |
LOWER RESPIRATORY TRACT INFECTION |
4 |
0.0001 |
| 482 |
NEOPLASM |
1 |
0.0001 |
| 483 |
PRODUCT SUBSTITUTION ISSUE |
5 |
0.0001 |
| 484 |
RASH MACULAR |
3 |
0.0001 |
| 485 |
MIGRAINE |
8 |
0.0001 |
| 486 |
MACULAR DEGENERATION |
1 |
0.0001 |
| 487 |
HYPERLIPIDAEMIA |
1 |
0.0001 |
| 488 |
LOCALISED INFECTION |
2 |
0.0001 |
| 489 |
FIBROMYALGIA |
2 |
0.0001 |
| 490 |
SMALL INTESTINAL OBSTRUCTION |
1 |
0.0001 |
| 491 |
PNEUMONIA |
26 |
0.0001 |
| 492 |
DIABETES MELLITUS |
6 |
0.0001 |
| 493 |
INJECTION SITE IRRITATION |
1 |
0.0001 |
| 494 |
OFF LABEL USE |
68 |
0.0001 |
| 495 |
INFUSION SITE PAIN |
1 |
0.0001 |
| 496 |
INJECTION SITE INDURATION |
1 |
0.0001 |
| 497 |
DEAFNESS |
2 |
0.0001 |
| 498 |
BEDRIDDEN |
1 |
0.0001 |
| 499 |
ORAL CANDIDIASIS |
1 |
0.0001 |
| 500 |
DYSMENORRHOEA |
1 |
0.0001 |
| 501 |
EYE HAEMORRHAGE |
1 |
0.0001 |
| 502 |
COVID-19 |
13 |
0.0001 |
| 503 |
EXTRA DOSE ADMINISTERED |
3 |
0.0001 |
| 504 |
THROAT TIGHTNESS |
2 |
0.0001 |
| 505 |
PERIPHERAL COLDNESS |
1 |
0.0001 |
| 506 |
MEMORY IMPAIRMENT |
10 |
0.0001 |
| 507 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
13 |
0.0001 |
| 508 |
FEELING COLD |
2 |
0.0001 |
| 509 |
APHONIA |
1 |
0.0001 |
| 510 |
DEMENTIA |
2 |
0.0001 |
| 511 |
MASS |
1 |
0.0001 |
| 512 |
CARPAL TUNNEL SYNDROME |
1 |
0.0001 |
| 513 |
RASH |
31 |
0.0001 |
| 514 |
SKIN REACTION |
1 |
0.0001 |
| 515 |
BLINDNESS UNILATERAL |
1 |
0.0001 |
| 516 |
HYPERSOMNIA |
2 |
0.0001 |
| 517 |
PARAESTHESIA ORAL |
1 |
0.0001 |
| 518 |
MENTAL DISORDER |
3 |
0.0001 |
| 519 |
INJECTION SITE HAEMATOMA |
1 |
0.0001 |
| 520 |
INTENTIONAL PRODUCT USE ISSUE |
6 |
0.0001 |
| 521 |
DRUG INEFFECTIVE |
90 |
0.0001 |
| 522 |
INSOMNIA |
18 |
0.0001 |
| 523 |
DEHYDRATION |
9 |
0.0001 |
| 524 |
GASTROINTESTINAL DISORDER |
6 |
0.0001 |
| 525 |
RESPIRATORY DISORDER |
2 |
0.0001 |
| 526 |
HYPOAESTHESIA ORAL |
1 |
0.0001 |
| 527 |
UNEVALUABLE EVENT |
5 |
0.0001 |
| 528 |
ECONOMIC PROBLEM |
1 |
0.0001 |
| 529 |
EPILEPSY |
2 |
0.0001 |
| 530 |
ADVERSE EVENT |
6 |
0.0001 |
| 531 |
TENDONITIS |
1 |
0.0001 |
| 532 |
EXPOSURE DURING PREGNANCY |
4 |
0.0001 |
| 533 |
BLOOD CHOLESTEROL INCREASED |
3 |
0.0001 |
| 534 |
THERAPY PARTIAL RESPONDER |
1 |
0.0001 |
| 535 |
SWOLLEN TONGUE |
2 |
0.0001 |
| 536 |
PRODUCT USE ISSUE |
12 |
0.0001 |
| 537 |
ABDOMINAL PAIN UPPER |
13 |
0.0001 |
| 538 |
DISEASE RECURRENCE |
3 |
0.0001 |
| 539 |
RENAL CANCER |
3 |
0.0001 |
| 540 |
MULTIPLE SCLEROSIS |
3 |
0.0001 |
| 541 |
SCIATICA |
1 |
0.0001 |
| 542 |
ASTHMA |
7 |
0.0001 |
| 543 |
MUSCLE TIGHTNESS |
1 |
0.0001 |
| 544 |
IMPAIRED HEALING |
2 |
0.0001 |
| 545 |
INFUSION RELATED REACTION |
4 |
0.0001 |
| 546 |
THERAPEUTIC RESPONSE SHORTENED |
2 |
0.0001 |
| 547 |
LIP SWELLING |
2 |
0.0001 |
| 548 |
ABDOMINAL DISCOMFORT |
10 |
0.0001 |
| 549 |
HOSPITALISATION |
9 |
0.0001 |
| 550 |
PARANOIA |
1 |
0.0001 |
| 551 |
PAIN IN EXTREMITY |
17 |
0.0001 |
| 552 |
SYRINGE ISSUE |
1 |
0.0001 |
| 553 |
HEAD DISCOMFORT |
1 |
0.0001 |
| 554 |
ABDOMINAL PAIN |
13 |
0.0001 |
| 555 |
TOOTHACHE |
1 |
0.0001 |
| 556 |
RESTLESS LEGS SYNDROME |
1 |
0.0001 |
| 557 |
PANIC ATTACK |
2 |
0.0001 |
| 558 |
TREATMENT NONCOMPLIANCE |
3 |
0.0001 |
| 559 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
1 |
0.0001 |
| 560 |
HAEMATOCHEZIA |
3 |
0.0001 |
| 561 |
INJECTION SITE MASS |
2 |
0.0001 |
| 562 |
NECK PAIN |
3 |
0.0001 |
| 563 |
BACTERIAL INFECTION |
1 |
0.0001 |
| 564 |
MIDDLE INSOMNIA |
1 |
0.0001 |
| 565 |
OXYGEN SATURATION DECREASED |
3 |
0.0001 |
| 566 |
HEPATIC CIRRHOSIS |
1 |
0.0001 |
| 567 |
INTESTINAL OBSTRUCTION |
2 |
0.0001 |
| 568 |
FRACTURE |
1 |
0.0001 |
| 569 |
MUSCULAR WEAKNESS |
6 |
0.0001 |
| 570 |
COLITIS |
2 |
0.0001 |
| 571 |
MALAISE |
23 |
0.0001 |
| 572 |
BLOOD PRESSURE INCREASED |
8 |
0.0001 |
| 573 |
HERPES ZOSTER |
3 |
0.0001 |
| 574 |
WHITE BLOOD CELL COUNT INCREASED |
2 |
0.0001 |
| 575 |
PRURITUS |
20 |
0.0001 |
| 576 |
CONTUSION |
5 |
0.0001 |
| 577 |
HERNIA |
1 |
0.0001 |
| 578 |
PRESCRIBED OVERDOSE |
1 |
0.0001 |
| 579 |
EAR PAIN |
1 |
0.0001 |
| 580 |
ALOPECIA |
10 |
0.0001 |
| 581 |
PARAESTHESIA |
8 |
0.0001 |
| 582 |
SINUS DISORDER |
1 |
0.0001 |
| 583 |
UPPER LIMB FRACTURE |
1 |
0.0001 |
| 584 |
ABORTION SPONTANEOUS |
2 |
0.0000 |
| 585 |
STOMATITIS |
3 |
0.0000 |
| 586 |
FEEDING DISORDER |
1 |
0.0000 |
| 587 |
PLEURAL EFFUSION |
3 |
0.0000 |
| 588 |
WEIGHT INCREASED |
11 |
0.0000 |
| 589 |
BODY TEMPERATURE INCREASED |
1 |
0.0000 |
| 590 |
FEELING HOT |
3 |
0.0000 |
| 591 |
OSTEOPOROSIS |
2 |
0.0000 |
| 592 |
INFECTION |
7 |
0.0000 |
| 593 |
TOOTH LOSS |
1 |
0.0000 |
| 594 |
POOR QUALITY SLEEP |
1 |
0.0000 |
| 595 |
HEADACHE |
29 |
0.0000 |
| 596 |
AMNESIA |
3 |
0.0000 |
| 597 |
SWELLING FACE |
3 |
0.0000 |
| 598 |
DYSPNOEA |
26 |
0.0000 |
| 599 |
PRODUCT PRESCRIBING ISSUE |
1 |
0.0000 |
| 600 |
CLOSTRIDIUM DIFFICILE INFECTION |
1 |
0.0000 |
| 601 |
PERIPHERAL SWELLING |
7 |
0.0000 |
| 602 |
LIVER DISORDER |
2 |
0.0000 |
| 603 |
CHROMATURIA |
1 |
0.0000 |
| 604 |
PRODUCT AVAILABILITY ISSUE |
1 |
0.0000 |
| 605 |
NEPHROLITHIASIS |
2 |
0.0000 |
| 606 |
SKIN DISCOLOURATION |
2 |
0.0000 |
| 607 |
RENAL DISORDER |
2 |
0.0000 |
| 608 |
PALPITATIONS |
5 |
0.0000 |
| 609 |
HYPERTENSION |
9 |
0.0000 |
| 610 |
RASH ERYTHEMATOUS |
2 |
0.0000 |
| 611 |
MOBILITY DECREASED |
3 |
0.0000 |
| 612 |
CEREBROVASCULAR ACCIDENT |
7 |
0.0000 |
| 613 |
MENTAL IMPAIRMENT |
1 |
0.0000 |
| 614 |
PRESYNCOPE |
1 |
0.0000 |
| 615 |
NEURALGIA |
1 |
0.0000 |
| 616 |
FATIGUE |
32 |
0.0000 |
| 617 |
VISUAL IMPAIRMENT |
5 |
0.0000 |
| 618 |
HYPOAESTHESIA |
6 |
0.0000 |
| 619 |
CARDIOVASCULAR DISORDER |
1 |
0.0000 |
| 620 |
NAUSEA |
31 |
0.0000 |
| 621 |
HYPOPHAGIA |
1 |
0.0000 |
| 622 |
DRUG RESISTANCE |
1 |
0.0000 |
| 623 |
HYPERHIDROSIS |
5 |
0.0000 |
| 624 |
ANAPHYLACTIC SHOCK |
1 |
0.0000 |
| 625 |
MUSCULOSKELETAL PAIN |
2 |
0.0000 |
| 626 |
JOINT STIFFNESS |
1 |
0.0000 |
| 627 |
DIZZINESS |
19 |
0.0000 |
| 628 |
GASTRITIS |
1 |
0.0000 |
| 629 |
PANCREATITIS |
2 |
0.0000 |
| 630 |
DEPRESSED MOOD |
2 |
0.0000 |
| 631 |
DISTURBANCE IN ATTENTION |
2 |
0.0000 |
| 632 |
FREQUENT BOWEL MOVEMENTS |
1 |
0.0000 |
| 633 |
DRY MOUTH |
3 |
0.0000 |
| 634 |
RASH PRURITIC |
2 |
0.0000 |
| 635 |
LIMB INJURY |
1 |
0.0000 |
| 636 |
PNEUMONITIS |
1 |
0.0000 |
| 637 |
GAIT DISTURBANCE |
7 |
0.0000 |
| 638 |
ANAPHYLACTIC REACTION |
2 |
0.0000 |
| 639 |
PROCEDURAL PAIN |
1 |
0.0000 |
| 640 |
SEPSIS |
4 |
0.0000 |
| 641 |
RENAL IMPAIRMENT |
3 |
0.0000 |
| 642 |
EYE PAIN |
2 |
0.0000 |
| 643 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
1 |
0.0000 |
| 644 |
FLATULENCE |
2 |
0.0000 |
| 645 |
BACK PAIN |
8 |
0.0000 |
| 646 |
LIVER FUNCTION TEST ABNORMAL |
1 |
0.0000 |
| 647 |
NEEDLE ISSUE |
1 |
0.0000 |
| 648 |
DYSPHONIA |
2 |
0.0000 |
| 649 |
CHILLS |
4 |
0.0000 |
| 650 |
VOMITING |
16 |
0.0000 |
| 651 |
TACHYCARDIA |
3 |
0.0000 |
| 652 |
WHEEZING |
2 |
0.0000 |
| 653 |
APHASIA |
1 |
0.0000 |
| 654 |
LACRIMATION INCREASED |
1 |
0.0000 |
| 655 |
THERAPEUTIC RESPONSE DECREASED |
2 |
0.0000 |
| 656 |
SUICIDAL IDEATION |
3 |
0.0000 |
| 657 |
MUSCLE SPASMS |
6 |
0.0000 |
| 658 |
ACUTE KIDNEY INJURY |
5 |
0.0000 |
| 659 |
NASOPHARYNGITIS |
6 |
0.0000 |
| 660 |
DIARRHOEA |
21 |
0.0000 |
| 661 |
OROPHARYNGEAL PAIN |
3 |
0.0000 |
| 662 |
LIMB DISCOMFORT |
1 |
0.0000 |
| 663 |
FEMUR FRACTURE |
1 |
0.0000 |
| 664 |
WEIGHT DECREASED |
9 |
0.0000 |
| 665 |
DYSPHAGIA |
3 |
0.0000 |
| 666 |
PULMONARY EMBOLISM |
3 |
0.0000 |
| 667 |
NEUROPATHY PERIPHERAL |
3 |
0.0000 |
| 668 |
MOOD SWINGS |
1 |
0.0000 |
| 669 |
MOVEMENT DISORDER |
1 |
0.0000 |
| 670 |
RHINORRHOEA |
2 |
0.0000 |
| 671 |
DEPRESSION |
7 |
0.0000 |
| 672 |
PRODUCT DOSE OMISSION ISSUE |
9 |
0.0000 |
| 673 |
CHOLELITHIASIS |
1 |
0.0000 |
| 674 |
FUNGAL INFECTION |
1 |
0.0000 |
| 675 |
TRANSIENT ISCHAEMIC ATTACK |
1 |
0.0000 |
| 676 |
SINUSITIS |
3 |
0.0000 |
| 677 |
DELIRIUM |
1 |
0.0000 |
| 678 |
BURNING SENSATION |
2 |
0.0000 |
| 679 |
INJURY |
2 |
0.0000 |
| 680 |
HYPOXIA |
1 |
0.0000 |
| 681 |
LYMPHADENOPATHY |
1 |
0.0000 |
| 682 |
PRODUCT USE IN UNAPPROVED INDICATION |
7 |
0.0000 |
| 683 |
ANXIETY |
8 |
0.0000 |
| 684 |
CEREBRAL HAEMORRHAGE |
1 |
0.0000 |
| 685 |
UNDERDOSE |
2 |
0.0000 |
| 686 |
AGITATION |
2 |
0.0000 |
| 687 |
DYSURIA |
1 |
0.0000 |
| 688 |
CHEST PAIN |
5 |
0.0000 |
| 689 |
EYE SWELLING |
1 |
0.0000 |
| 690 |
DYSARTHRIA |
1 |
0.0000 |
| 691 |
PYREXIA |
9 |
0.0000 |
| 692 |
CARDIAC FAILURE CONGESTIVE |
2 |
0.0000 |
| 693 |
GASTROOESOPHAGEAL REFLUX DISEASE |
2 |
0.0000 |
| 694 |
FOETAL EXPOSURE DURING PREGNANCY |
2 |
0.0000 |
| 695 |
BLINDNESS |
1 |
0.0000 |
| 696 |
TREMOR |
4 |
0.0000 |
| 697 |
URINARY TRACT INFECTION |
4 |
0.0000 |
| 698 |
HYPOACUSIS |
1 |
0.0000 |
| 699 |
VAGINAL HAEMORRHAGE |
1 |
0.0000 |
| 700 |
CONSTIPATION |
5 |
0.0000 |
| 701 |
INTENTIONAL PRODUCT MISUSE |
2 |
0.0000 |
| 702 |
ANGIOEDEMA |
1 |
0.0000 |
| 703 |
DRY SKIN |
3 |
0.0000 |
| 704 |
THROAT IRRITATION |
1 |
0.0000 |
| 705 |
PRODUCT QUALITY ISSUE |
3 |
0.0000 |
| 706 |
INCORRECT DOSE ADMINISTERED |
5 |
0.0000 |
| 707 |
VISION BLURRED |
3 |
0.0000 |
| 708 |
SKIN IRRITATION |
1 |
0.0000 |
| 709 |
UPPER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 710 |
BREAST CANCER |
2 |
0.0000 |
| 711 |
COUGH |
6 |
0.0000 |
| 712 |
CARDIAC DISORDER |
2 |
0.0000 |
| 713 |
OCULAR HYPERAEMIA |
1 |
0.0000 |
| 714 |
ANAEMIA |
4 |
0.0000 |
| 715 |
PRODUCTIVE COUGH |
1 |
0.0000 |
| 716 |
FEELING ABNORMAL |
5 |
0.0000 |
| 717 |
INTERSTITIAL LUNG DISEASE |
1 |
0.0000 |
| 718 |
HEART RATE INCREASED |
2 |
0.0000 |
| 719 |
CELLULITIS |
1 |
0.0000 |
| 720 |
FLUSHING |
2 |
0.0000 |
| 721 |
FLUID RETENTION |
1 |
0.0000 |
| 722 |
ERYTHEMA |
4 |
0.0000 |
| 723 |
SPEECH DISORDER |
1 |
0.0000 |
| 724 |
ASTHENIA |
7 |
0.0000 |
| 725 |
CONFUSIONAL STATE |
3 |
0.0000 |
| 726 |
OEDEMA |
1 |
0.0000 |
| 727 |
MEDICATION ERROR |
1 |
0.0000 |
| 728 |
DEATH |
15 |
0.0000 |
| 729 |
EYE IRRITATION |
1 |
0.0000 |
| 730 |
SEIZURE |
2 |
0.0000 |
| 731 |
BONE PAIN |
1 |
0.0000 |
| 732 |
NASAL CONGESTION |
1 |
0.0000 |
| 733 |
DISEASE PROGRESSION |
2 |
0.0000 |
| 734 |
CATARACT |
1 |
0.0000 |
| 735 |
NO ADVERSE EVENT |
3 |
0.0000 |
| 736 |
EMOTIONAL DISTRESS |
2 |
0.0000 |
| 737 |
OEDEMA PERIPHERAL |
2 |
0.0000 |
| 738 |
LOSS OF CONSCIOUSNESS |
2 |
0.0000 |
| 739 |
DEEP VEIN THROMBOSIS |
1 |
0.0000 |
| 740 |
FALL |
5 |
0.0000 |
| 741 |
HYPOTENSION |
3 |
0.0000 |
| 742 |
SOMNOLENCE |
3 |
0.0000 |
| 743 |
SKIN BURNING SENSATION |
1 |
0.0000 |
| 744 |
RESPIRATORY FAILURE |
1 |
0.0000 |
| 745 |
EPISTAXIS |
1 |
0.0000 |
| 746 |
DECREASED APPETITE |
3 |
0.0000 |
| 747 |
CARDIAC FAILURE |
1 |
0.0000 |
| 748 |
INFLUENZA LIKE ILLNESS |
1 |
0.0000 |
| 749 |
GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0000 |
| 750 |
SKIN EXFOLIATION |
1 |
0.0000 |
| 751 |
BALANCE DISORDER |
1 |
0.0000 |
| 752 |
MYOCARDIAL INFARCTION |
2 |
0.0000 |
| 753 |
ATRIAL FIBRILLATION |
1 |
0.0000 |
| 754 |
CHEST DISCOMFORT |
1 |
0.0000 |
| 755 |
HAEMOGLOBIN DECREASED |
1 |
0.0000 |
| 756 |
OVERDOSE |
2 |
0.0000 |
| 757 |
WHITE BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 758 |
INFLUENZA |
1 |
0.0000 |
| 759 |
NEUTROPENIA |
1 |
0.0000 |
| 760 |
DRUG INTERACTION |
1 |
0.0000 |
| 761 |
DRUG DEPENDENCE |
1 |
0.0000 |